EXER-CARDIOKINE Trademark

Trademark Overview

On Tuesday, July 30, 2013, a trademark application was filed for EXER-CARDIOKINE with the United States Patent and Trademark Office. The USPTO has given the EXER-CARDIOKINE trademark a serial number of 86023659. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, September 14, 2017. The EXER-CARDIOKINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparation for treating all cardiovascular related diseases, disorders or conditions; pharmaceutical namely oral, inhalational, parenteral, topical pharmaceuticals containing proteins, protein kinase or phosphatas; nutraceuticals, vitamins, minerals, nutritional and dietary supplements for the treatment of all cardiovascular related diseases, disorders or conditions

Medical and scientific research in the field of cardiovascular related diseases, disorders or conditions; Medical research; Pharmaceutical research and development
exer-cardiokine

General Information

Serial Number86023659
Word MarkEXER-CARDIOKINE
Filing DateTuesday, July 30, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, September 14, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparation for treating all cardiovascular related diseases, disorders or conditions; pharmaceutical namely oral, inhalational, parenteral, topical pharmaceuticals containing proteins, protein kinase or phosphatas; nutraceuticals, vitamins, minerals, nutritional and dietary supplements for the treatment of all cardiovascular related diseases, disorders or conditions
Goods and ServicesMedical and scientific research in the field of cardiovascular related diseases, disorders or conditions; Medical research; Pharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 6, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 3, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressHamilton, Ontario L8S4C9
CA

Trademark Events

Event DateEvent Description
Thursday, September 14, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, September 14, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, February 10, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, February 10, 2017INQUIRY TO SUSPENSION E-MAILED
Friday, February 10, 2017SUSPENSION INQUIRY WRITTEN
Monday, January 23, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, July 22, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 22, 2016LETTER OF SUSPENSION E-MAILED
Friday, July 22, 2016SUSPENSION LETTER WRITTEN
Friday, July 22, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 22, 2016LETTER OF SUSPENSION E-MAILED
Friday, July 22, 2016SUSPENSION LETTER WRITTEN
Thursday, July 14, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 13, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 29, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 29, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, January 29, 2016SUSPENSION INQUIRY WRITTEN
Wednesday, January 20, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, July 15, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 15, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, July 15, 2015SUSPENSION LETTER WRITTEN
Tuesday, July 14, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 14, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, January 10, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, January 10, 2015INQUIRY TO SUSPENSION E-MAILED
Saturday, January 10, 2015SUSPENSION INQUIRY WRITTEN
Wednesday, December 24, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, June 20, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 20, 2014LETTER OF SUSPENSION E-MAILED
Friday, June 20, 2014SUSPENSION LETTER WRITTEN
Tuesday, June 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 23, 2014ASSIGNED TO LIE
Monday, May 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 18, 2013NON-FINAL ACTION E-MAILED
Monday, November 18, 2013NON-FINAL ACTION WRITTEN
Wednesday, November 13, 2013ASSIGNED TO EXAMINER
Tuesday, August 6, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

cardiokine exer disorders conditions pharmaceutical diseases research related cardiovascular medical nutritional minerals